Fig. 7From: Establishment of tumor microenvironment-preserving organoid model from patients with intracranial meningiomaSchematic diagram of this study. A patient-derived MNO model, which includes diverse cell types of the tumor microenvironment and is practicable for cryopreserving-recovery cycles, was established. Biological and genetic features were validated using diverse in vitro assays and WES. Drug screening was performed as a representative application of MNO modelBack to article page